Skip Nav Destination
Clinical Pharmacology
Edited by
S.Karger AG
Status:
Available
ISBN electronic:
978-3-318-04429-4
ISBN print:
978-3-8055-2502-2
Publication date:
1973
Clinical Pharmacology
Edited by: B.B. Brodie, R. Domenjoz, E.S. Vesell
https://doi.org/10.1159/isbn.978-3-318-04429-4
ISBN (print): 978-3-8055-2502-2
ISBN (electronic): 978-3-318-04429-4
Publisher: S.Karger AG
Published: 1973
Download citation file:
Digital Version
Pay-Per-View Access
$34.00
Print Version
Clinical Pharmacology
$34.00
Table of Contents
-
129 - 137: Identification of 5-(3,4-Dihydroxyphenyl)-5-Phenylhydantoin as a Metabolite of 5,5-Diphenylhydantoin (Phenytoin) in Rats and ManByO. Borgå;O. BorgåDepartments of Pharmacology and Clinical Pharmacology and Department of Toxicology, Swedish Medical Research Council, Karolinska Institute, StockholmSearch for other works by this author on:M. Garle;M. GarleDepartments of Pharmacology and Clinical Pharmacology and Department of Toxicology, Swedish Medical Research Council, Karolinska Institute, StockholmSearch for other works by this author on:Marcela GutováMarcela GutováDepartments of Pharmacology and Clinical Pharmacology and Department of Toxicology, Swedish Medical Research Council, Karolinska Institute, StockholmSearch for other works by this author on:
-
138 - 148: Morphine-Induced Redistribution of Cardiac Output in the Unanesthetized Monkey1ByR. L. Miller;R. L. MillerDivision of Clinical Pharmacology, Cardiovascular Research Institute, and Departments of Medicine and Pharmacology, University of California, San Francisco Medical Center, San Francisco, Calif.Search for other works by this author on:R. P. Forsyth;R. P. ForsythDivision of Clinical Pharmacology, Cardiovascular Research Institute, and Departments of Medicine and Pharmacology, University of California, San Francisco Medical Center, San Francisco, Calif.Search for other works by this author on:K. L. MelmonK. L. MelmonDivision of Clinical Pharmacology, Cardiovascular Research Institute, and Departments of Medicine and Pharmacology, University of California, San Francisco Medical Center, San Francisco, Calif.Search for other works by this author on:
-
149 - 158: Vitamin K and Oral Anticoagulant Drugs as Competitive Antagonists in Man1ByR. A. O’ReillyR. A. O’ReillyDepartments of Medicine, Santa Clara Valley Medical Center, San Jose, Stanford University School of Medicine, Palo Alto, University of California School of Medicine, San Francisco, and Institute for Medical Research of Santa Clara County, San Jose, Calif.Search for other works by this author on:
-
159 - 168: The Disposition of PropranololByD. G. Shand;D. G. ShandDivision of Clinical Pharmacology, Departments of Medicine and Pharmacology, Vanderbilt University, Nashville, Tenn.Search for other works by this author on:R. E. RangnoR. E. RangnoDivision of Clinical Pharmacology, Departments of Medicine and Pharmacology, Vanderbilt University, Nashville, Tenn.Search for other works by this author on:
-
169 - 177: The Alteration of Plasma Proteins in Uremia as Reflected in their Ability to Bind Digitoxin and Diphenylhydantoin1ByD. W. Shoeman;D. W. ShoemanClinical Pharmacology-Toxicology Center, Departments of Medicine and Pharmacology, University of Kansas Medical Center, Kansas City, Kans.Search for other works by this author on:D. L. AzarnoffD. L. AzarnoffClinical Pharmacology-Toxicology Center, Departments of Medicine and Pharmacology, University of Kansas Medical Center, Kansas City, Kans.Search for other works by this author on:
-
178 - 184: Relation of Propranolol Plasma Level to β-Blockade during Oral TherapyByR. Zacest;R. ZacestClinical Pharmacology Unit, Departments of Medicine and Pharmacology, Massachusetts General Hospital and Harvard Medical School, Boston, Mass.Search for other works by this author on:J. Koch-WeserJ. Koch-WeserClinical Pharmacology Unit, Departments of Medicine and Pharmacology, Massachusetts General Hospital and Harvard Medical School, Boston, Mass.Search for other works by this author on:
-
185 - 196: The Energy Cost of the Metabolism of Drugs, Including EthanolByR. C. Pirola;R. C. PirolaDepartment of Medicine, Mount Sinai School of Medicine of the City University of New York, and the Section of Liver Disease and Nutrition, Veterans Administration Hospital, Bronx, N.Y.Search for other works by this author on:C. S. LieberC. S. LieberDepartment of Medicine, Mount Sinai School of Medicine of the City University of New York, and the Section of Liver Disease and Nutrition, Veterans Administration Hospital, Bronx, N.Y.Search for other works by this author on:
-
197 - 206: Effects of Chronic Prazepam Administration on Drug Metabolism in Man and RatByE. S. Vesell;E. S. VesellDepartment of Pharmacology, Pennsylvania State University College of Medicine, Milton S. Hershey Medical Center, Hershey, Pa., and the Drug Metabolism Department, Warner-Lambert Research Institute, Morris Plains, N.J.Search for other works by this author on:G. T. Passananti;G. T. PassanantiDepartment of Pharmacology, Pennsylvania State University College of Medicine, Milton S. Hershey Medical Center, Hershey, Pa., and the Drug Metabolism Department, Warner-Lambert Research Institute, Morris Plains, N.J.Search for other works by this author on:J.-P. Viau;J.-P. ViauDepartment of Pharmacology, Pennsylvania State University College of Medicine, Milton S. Hershey Medical Center, Hershey, Pa., and the Drug Metabolism Department, Warner-Lambert Research Institute, Morris Plains, N.J.Search for other works by this author on:J. E. Epps;J. E. EppsDepartment of Pharmacology, Pennsylvania State University College of Medicine, Milton S. Hershey Medical Center, Hershey, Pa., and the Drug Metabolism Department, Warner-Lambert Research Institute, Morris Plains, N.J.Search for other works by this author on:F. J. Di CarloF. J. Di CarloDepartment of Pharmacology, Pennsylvania State University College of Medicine, Milton S. Hershey Medical Center, Hershey, Pa., and the Drug Metabolism Department, Warner-Lambert Research Institute, Morris Plains, N.J.Search for other works by this author on:
